The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
Open accessAbstract
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly becoming the key investigative tool for the staging and assessment of cancer recurrence. In the last 5 y, PET/CT has also gained widespread acceptance as a key tool used to demonstrate early response to intervention and therapy. In this setting, a major clinical need is being addressed with 18F-FDG PET/CT, because of its inherent ability to demonstrate (before other markers of response) if disease modification has occurred. This review presents available evidence to this effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
Pieterman, R. M., van Putten, J. W. G., Meuzelaar, J. J., Mooyaart, E. L., Vaalburg, W., Koëter, G. H., Fidler, V., Pruim, J., & Groen, H. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430404 · Cited by 1,111
Fisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B., Foster, R., Gardner, B., Lerner, H., Margolese, R., et al. (1983) · Cancer · doi:10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3 · Cited by 1,034
Lordick, F., Ott, K., Krause, B.-J., Weber, W. A., Becker, K., Stein, H. J., Lorenzen, S., Schuster, T., Wieder, H., Herrmann, K., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70244-9 · Cited by 804
Positron-Emission Tomography and Assessment of Cancer Therapy
Juweid, M. E., & Cheson, B. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050276 · Cited by 750
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 674
Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
We Should Desist Using RECIST, at Least in GIST
Benjamin, R. S., Choi, H., Macapinlac, H. A., Burgess, M. A., Patel, S. R., Chen, L. L., Podoloff, D. A., & Charnsangavej, C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3411 · Cited by 559
Weber, W. A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., & Schwaiger, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.004 · Cited by 493
Kayani, I., Bomanji, J. B., Groves, A., Conway, G., Gacinovic, S., Win, T., Dickson, J., Caplin, M., & Ell, P. J. (2008) · Cancer · doi:10.1002/cncr.23469 · Cited by 477
Self-citationWieder, H. A., Brücher, B. L. D. M., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Schwaiger, M., Fink, U., Siewert, J. R., Stein, H. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.122 · Cited by 454
Lin, C., Itti, E., Haioun, C., Petegnief, Y., Luciani, A., Dupuis, J., Paone, G., Talbot, J.-N., Rahmouni, A., & Meignan, M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042093 · Cited by 394
Juweid, M. E., Wiseman, G. A., Vose, J. M., Ritchie, J. M., Menda, Y., Wooldridge, J. E., Mottaghy, F. M., Rohren, E. M., Blumstein, N. M., Stolpen, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.891 · Cited by 387
Hillner, B. E., Siegel, B. A., Liu, D., Shields, A. F., Gareen, I. F., Hanna, L., Stine, S. H., & Coleman, R. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5631 · Cited by 374
Wahl, R. L., Siegel, B. A., Coleman, R. E., & Gatsonis, C. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.148 · Cited by 345
Antoch, G., Kanja, J., Bauer, S., Kuehl, H., Renzing-Koehler, K., Schuette, J., Bockisch, A., Debatin, J. F., & Freudenberg, L. S. (2004) · PubMed · Cited by 312
Westerterp, M., van Westreenen, H. L., Reitsma, J. B., Hoekstra, O. S., Stoker, J., Fockens, P., Jager, P. L., Van Eck-Smit, B. L. F., Plukker, J. T. M., van Lanschot, J. J. B., et al. (2005) · Radiology · doi:10.1148/radiol.2363041042 · Cited by 299
Avril, N., Sassen, S., Schmalfeldt, B., Naehrig, J., Rutke, S., Weber, W. A., Werner, M., Graeff, H., Schwaiger, M., & Kuhn, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.965 · Cited by 283
Brun, E., Kjellén, E., Tennvall, J., Ohlsson, T., Sandell, A., Perfekt, R., Perfekt, R., Wennerberg, J., & Strand, S. E. (2002) · Head & Neck · doi:10.1002/hed.10037 · Cited by 251
Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., van Tinteren, H., Postmus, P. E., Golding, R. P., Biesma, B., Schramel, F. J. H. M., van Zandwijk, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1189 · Cited by 247
Haberkorn, U., Strauss, L. G., Dimitrakopoulou, A., Engenhart, R., Oberdorfer, F., Ostertag, H. J., Romahn, J., & KAICK, G. V. (1991) · PubMed · Cited by 241
Cascini, G. L., Avallone, A., Delrio, P., Guida, C., Tatangelo, F., Marone, P., Aloj, L., Martinis, F. D., Comella, P., Parisi, V., et al. (2006) · PubMed · Cited by 231
Israel, O., Yefremov, N., Bar‐Shalom, R., Kagana, O., Frenkel, A., Keidar, Z., & Fischer, D. (2005) · PubMed · Cited by 229
Schwarz, J., Bader, M., Jenicke, L., Hemminger, G., Jänicke, F., & Avril, N. E. (2005) · PubMed · Cited by 227
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Thomas, J., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3842 · Cited by 226
Denecke, T., Rau, B., Hoffmann, K.-T., Hildebrandt, B., Ruf, J., Gutberlet, M., Hünerbein, M., Felix, R., Wust, P., & Amthauer, H. (2005) · European Radiology · doi:10.1007/s00330-005-2658-4 · Cited by 205
Cerfolio, R. J., Bryant, A. S., Winokur, T. S., Ohja, B., & Bartolucci, A. A. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.06.102 · Cited by 195
Guillem, J. G., Moore, H. G., Akhurst, T., Klimstra, D. S., Ruo, L., Mazumdar, M., Minsky, B. D., Saltz, L., Wong, D. W., & Larson, S. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.02.024 · Cited by 192
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
Berriolo-Riedinger, A., Touzery, C., Riedinger, J.-M., Toubeau, M., Coudert, B., Arnould, L., Boichot, C., Cochet, A., Fumoleau, P., & Brunotte, F. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0459-5 · Cited by 180
Capirci, C., Rampin, L., Erba, P. A., Galeotti, F., Crepaldi, G., Banti, E., Gava, M., Fanti, S., Mariani, G., Muzzio, P. C., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0426-1 · Cited by 179
Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
Ito, K., Kato, T., Tadokoro, M., Ishiguchi, T., Oshima, M., Ishigaki, T., & Sakuma, S. (1992) · Radiology · doi:10.1148/radiology.182.2.1732979 · Cited by 177
Kostakoğlu, L., & Goldsmith, S. J. (2003) · PubMed · Cited by 172
Realizing the promise of personalized medicine.
Aspinall, M. G., & Hamermesh, R. G. (2007) · PubMed · Cited by 167
Langenhoff, B. S., Oyen, W. J. G., Jager, G. J., Strijk, S. P., Wobbes, T., Corstens, F. H. M., & Ruers, T. J. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.134 · Cited by 149
The contribution of PET/CT to improved patient management
Ell, P. J. (2006) · The British Journal of Radiology · doi:10.1259/bjr/18454286 · Cited by 128
Self-citationWust, P., Amthauer, H., Denecke, T., Rau, B., Ruf, J., Schneider, U., H�nerbein, M., Gutberlet, M., Schlag, P. M., Felix, R., et al. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1453-1 · Cited by 126
Eschmann, S. M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., Langen, H.-J., & Bares, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0273-5 · Cited by 126
Meta, J., Seltzer, M., Schiepers, C., Silverman, D. H. S., Ariannejad, M., Gambhir, S. S., Phelps, M. E., Valk, P. E., & Czernin, J. G. (2001) · PubMed · Cited by 119
Benz, M., Evilevitch, V., Allen-Auerbach, M., Eilber, F. C., Phelps, M. E., Czernin, J. G., & Weber, W. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.050187 · Cited by 117
Fueger, B. J., Weber, W., Quon, A. S. W., Crawford, T. L., Allen-Auerbach, M., Halpern, B. S., Ratib, O. M., Phelps, M. E., & Czernin, J. G. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0013-4 · Cited by 112
Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer
de Geus‐Oei, L., van Laarhoven, H. W. M., Visser, E. P., Hermsen, R., van Hoorn, B. A., Kamm, Y. J. L., Krabbe, P. F. M., Corstens, F. H. M., Punt, C. J. A., & Oyen, W. J. G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm470 · Cited by 112
The role of FDG-PET/CT in the detection of recurrent colorectal cancer
Votrubova, J., Bělohlávek, O., Jarůšková, M., Oliverius, M., Lohynská, R., Trskova, K., Sedláčková, E., Lipská, L., & Stahalova, V. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0072-z · Cited by 105
Wieder, H. A., Ott, K., Lordick, F., Becker, K., Stahl, A. R., Herrmann, K., Fink, U., Siewert, J. R., Schwaiger, M., & Weber, W. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0521-3 · Cited by 105
Goodgame, B. W., Pillot, G. A., Yang, Z., Shriki, J. E., Meyers, B. F., Zoole, J. B., Gao, F., Dehdashti, F., Patterson, A., Siegel, B. A., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318160c122 · Cited by 102
Moore, H. G., Akhurst, T. J., Larson, S. M., Minsky, B. D., Mazumdar, M., & Guillem, J. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00337-5 · Cited by 84
Guo, H., Zhu, H. J., Xi, Y., Zhang, B., Li, L., Huang, Y., Zhang, J., Fu, Z.-M., Yang, G., Yuan, S., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.036509 · Cited by 84
The Future in Diagnosis and Staging of Lung Cancer: Positron Emission Tomography
Fischer, B. M., & Mortensen, J. (2006) · Respiration · doi:10.1159/000092080 · Cited by 55
18F-FDG PET in Non-Hodgkin's Lymphoma: Qualitative or Quantitative?
Weber, W. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042911 · Cited by 55
Avril, N. E., & Adler, L. P. (2007) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2007.05.004 · Cited by 53
FDG-PET in monitoring therapy of breast cancer
Biersack, H. J., Bender, H., & PALMEDO, H. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1533-x · Cited by 49
Pillot, G. A., Siegel, B. A., & Govindan, R. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31531-8 · Cited by 42
S-100B and FDG-PET/CT in Therapy Response Assessment of Melanoma Patients
Strobel, K., Skalsky, J., Steinert, H. C., Dummer, R., Hany, T. F., Bhure, U., Seifert, B., Lago, M. P., Joller‐Jemelka, H. I., & Kalff, V. (2007) · Dermatology · doi:10.1159/000106575 · Cited by 37
Hart, D. P., Avivi, I. M., Thomson, K. J., Peggs, K. S., Morris, E. C., Goldstone, A. H., Linch, D. C., Ell, P. J., Bomanji, J. B., & Mackinnon, S. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05388.x · Cited by 36
Self-citationIntegrated PET-CT Imaging: Implications for Evaluation of Patients with Colorectal Carcinoma
Delbeke, D. (2005) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2005.08.001 · Cited by 2
Research works printed but not linked: 33
- 10.1016/S0140-6736(08)60956-3 · DOI
- 2007, Harv Bus Rev., 85, 108
- 2007, Eur J Cancer., 43, 1642
- 2004, J Nucl Med., 45, 357
- 2006, J Nucl Med., 47, 1059
- 10.1016/S1470-2045(07)70274-7 · DOI
- 1997, CA Cancer J Clin., 47, 323, 10.3322/canjclin.47.6.323 · doi:10.3322/canjclin.47.6.323
- 10.1002/ajh.21158 · doi:10.1002/ajh.21158
- 10.3324/haematol.12013 · doi:10.3324/haematol.12013
- 10.2967/jnumed.107.046292 · doi:10.2967/jnumed.107.046292
- 10.1007/s00259-004-1536-7 · DOI
- 10.1002/cncr.22292 · doi:10.1002/cncr.22292
- 2003, J Nucl Med., 44, 224
- 2002, J Nucl Med., 43, 325
- 2005, J Nucl Med., 46, 1144
- 10.1200/JCO.2006.05.7406 · doi:10.1200/jco.2006.05.7406
- 10.1097/01243894-200602000-00009 · doi:10.1097/01243894-200602000-00009
- 10.1016/j.crad.2008.01.012 · doi:10.1016/j.crad.2008.01.012
- 2008, Nucl Med Commun., 29, 4, 10.1097/MNM.0b013e3282f1b9c7 · DOI
- 2004, Appl Radiol., 33, 9
- 2005, J Nucl Med., 46, 758
- 2001, J Nucl Med., 42, 586
- 10.1016/S0959-8049(01)00049-1 · doi:10.1016/s0959-8049(01)00049-1
- 10.1016/j.ejso.2005.07.010 · doi:10.1016/j.ejso.2005.07.010
- 1991, J Nucl Med., 32, 1485
- 2005, Eur Radiol., 165, 1658
- 2004, J Am Coll Surg., 199, 1
- 2006, J Nucl Med., 47, 1241
- 10.1007/s00259-007-0627-7 · doi:10.1007/s00259-007-0627-7
- 10.1002/hed.20080 · doi:10.1002/hed.20080
- 2005, Lung Cancer., 49, S33
- 10.1016/j.ygyno.2004.08.037 · doi:10.1016/j.ygyno.2004.08.037
- 10.1200/JCO.2004.09.035 · doi:10.1200/jco.2004.09.035
Cited by
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 947
Metabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 711
Tixier, F., Le Rest, C. C., Hatt, M., Albarghach, N., Pradier, O., Metges, J.-P., Corcos, L., & Visvikis, D. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082404 · Cited by 696
Metadata
- Authors
- Ben-Haim, S., & Ell, P.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2009-01
- Volume
- 50
- Issue
- 1
- Pages
- 88-99
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2095520368
- Cited by
- 351
- References
- 59
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.